Lek, a Sandoz company, among the most reputable employers in Slovenia
As a part of the annual career fair Moje Delo 2011, the awards were conferred to the most reputable Slovenian companies according to an ‘Employer Reputation 2011’ survey. The survey is conducted by the recruitment portal MojeDelo.com (MyJob.com) biannually. This year’s survey is the third in a row and Lek, a Sandoz company, has been for the third time placed in the group of the most reputable employers in Slovenia.
Samo Roš, Head of Human Resources and Member of the Lek Board of Management, said upon receiving the award: »We are delighted to be positioned among the most reputable employers by the candidates in the labour market and that our efforts in this area are recognized. Employment at Lek, a Sandoz company, namely offers many career development opportunities in Slovenia and a unique opportunity to work in international development and research teams in the field of pharmacy. As a part of a global pharmaceutical company we have access to top expertise and equipment and additionally we invest heavily in the training and knowledge development of our associates. We have also adopted a range of measures to enable families a more efficient work-home balance for which we received a full Family Friendly Company certificate as one of the first companies in Slovenia.«
Nearly three thousand respondents took part in the survey
For the MojeDelo.com recruitment portal, the survey was prepared by Dr Marko Pahor from the Faculty of Economics, University of Ljubljana, and Dr Valentina Franca from The Faculty of Management Koper. In the survey, the reputation of companies or their employer brand equity was determined with the help of the so called reputation quotient which is based on the combination of three criteria and can have values from 0 to 1. The first criteria is company recognition among candidates in the labour market, the second criteria is considering the organisation as a potential employer among the candidates and the third one represents the so called level of being an employer of choice, which means that for candidates in the labour market the organization is the first choice potential employer and is very attractive for them.
»Based on the combination of these three criteria, the companies were selected that, according to the opinion of nearly 3,000 respondents, were most attractive among candidates in the labour market and consequently most respected. They all achieved the reputation quotient value of 0.81 or more and in all three parameters achieved nearly optimal values,« explained the MojeDelo.com portal.
Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. Its role within Sandoz is to act as: a global development center for products and technologies; a global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar products; and, a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and Commonwealth of Independent States (CIS), and it is responsible for sales on the Slovenian market. For further information please visit http://www.lek.si/eng/.
Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by valid and enforceable third-party patents. Sandoz has a portfolio of approximately 1000 compounds and sells its products in about 130 countries. Key product groups include cardiovascular medicines, anti-infectives, treatments for central nervous system and alimentary tract disorders, oncology and respiratory therapies, as well as medications for blood and blood forming organ disorders. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany), Eon Labs (US), EBEWE Pharma (Austria), and Oriel Therapeutics (US). In 2010, Sandoz employed more than 23,000 people (full-time equivalents) worldwide and achieved net sales of USD 8,5 billion for the full year.
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools. Novartis is the only company with leading positions in these areas. In 2010, the Group’s continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For further information contact:
Lek Pharmaceuticals d.d.
Phone: + 386 1 580 22 43
Fax: + 386 1 580 24 32